论文部分内容阅读
目的:探讨甘精胰岛素治疗2型糖尿病的的临床价值。方法:选取我院自2012年8月-2014年12月间收治的68例2型糖尿病患者作为研究对象,随机将其分成两组,即对照组患者34例采用赖脯胰岛素治疗,观察组患者34例采用甘精胰岛素治疗,对比两组患者的空腹血糖情况和餐后2h血糖情况等。结果:两组患者的空腹血糖含量差异不具有统计学意义,且观察组患者使用的胰岛素剂量低于对照组,对比差异具有统计学意义,P<0.05。结论:在治疗2型糖尿病时采用甘精胰岛素效果显著且用量更少,治疗费用更低因此值得推广使用。
Objective: To investigate the clinical value of insulin glargine in the treatment of type 2 diabetes mellitus. Methods: A total of 68 patients with type 2 diabetes mellitus admitted to our hospital from August 2012 to December 2014 were selected and randomly divided into two groups: 34 patients in the control group were treated with insulin lispro and the patients in the observation group 34 cases were treated with insulin glargine, fasting blood glucose and postprandial 2h blood glucose were compared between the two groups. Results: There was no significant difference in fasting plasma glucose between the two groups, and the insulin dose in the observation group was lower than that in the control group. The difference was statistically significant (P <0.05). CONCLUSIONS: The use of insulin glargine in the treatment of type 2 diabetes is significantly more effective and requires less dosage, resulting in lower cost of treatment and is therefore worth promoting.